Elixinol Wellness Limited (ASX:EXL)
Australia · Delayed Price · Currency is AUD 0.0170
0.00 (0.00%)
Aug 5, 2025, 1:26 PM AEST
Chimerix Market Cap
Elixinol Wellness has a market cap or net worth of 3.91 million as of August 6, 2025. Its market cap has decreased by -25.95% in one year.
Market Cap
3.91M
Enterprise Value
4.78M
Revenue
14.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 8, 2018, Elixinol Wellness's market cap has decreased from 149.25M to 3.91M, a decrease of -97.38%. That is a compound annual growth rate of -38.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 3.91M | -53.36% |
| Dec 31, 2024 | 8.39M | 10.49% |
| Dec 29, 2023 | 7.59M | 14.40% |
| Dec 30, 2022 | 6.64M | -70.81% |
| Dec 31, 2021 | 22.75M | -58.52% |
| Dec 31, 2020 | 54.84M | -29.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.54B |
| Pro Medicus | 33.39B |
| Cochlear | 20.50B |
| Sonic Healthcare | 13.80B |
| Ramsay Health Care | 8.81B |
| Telix Pharmaceuticals | 6.29B |
| Ansell | 4.47B |
| Mesoblast | 3.11B |